3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine
C85H96FN27O5 — CID 157084108
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine
3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine (PubChem CID 157084108) has the molecular formula C85H96FN27O5 and a molecular weight of 1594.88 g/mol. Its IUPAC name is 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine.
Molecular Properties
| Compound Name | 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine |
|---|---|
| PubChem CID | 157084108 |
| Molecular Formula | C85H96FN27O5 |
| Molecular Weight | 1594.88 g/mol |
| Exact Mass | 1593.81 |
| IUPAC Name | 3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazine-2-carboxylic acid;1-[3-amino-6-(3-methylimidazo[1,2-a]pyridin-6-yl)-5-(1,3-oxazol-2-yl)pyrazin-2-yl]-3-[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]propan-1-one;6-fluoropyridine-2-carbonitrile;(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane;6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]pyridine-2-carbonitrile;[6-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl]-2-pyridinyl]methanamine |
| SMILES | CN1C[C@H]2CC[C@@H](C1)N2.CN1C[C@H]2CC[C@@H](C1)N2c1cccc(C#N)n1.CN1C[C@H]2CC[C@@H](C1)N2c1cccc(CN)n1.Cc1cnc2ccc(-c3nc(C(=O)CCc4cccc(N5[C@@H]6CC[C@H]5CN(C)C6)n4)c(N)nc3-c3ncco3)cn12.Cc1cnc2ccc(-c3nc(C(=O)O)c(N)nc3-c3ncco3)cn12.N#Cc1cccc(F)n1 |
| InChI | InChI=1S/C30H31N9O2.C16H12N6O3.C13H20N4.C13H16N4.C7H14N2.C6H3FN2/c1-18-14-33-24-11-6-19(15-38(18)24)26-28(30-32-12-13-41-30)36-29(31)27(35-26)23(40)10-7-20-4-3-5-25(34-20)39-21-8-9-22(39)17-37(2)16-21;1-8-6-19-10-3-2-9(7-22(8)10)11-12(15-18-4-5-25-15)21-14(17)13(20-11)16(23)24;2*1-16-8-11-5-6-12(9-16)17(11)13-4-2-3-10(7-14)15-13;1-9-4-6-2-3-7(5-9)8-6;7-6-3-1-2-5(4-8)9-6/h3-6,11-15,21-22H,7-10,16-17H2,1-2H3,(H2,31,36);2-7H,1H3,(H2,17,21)(H,23,24);2-4,11-12H,5-9,14H2,1H3;2-4,11-12H,5-6,8-9H2,1H3;6-8H,2-5H2,1H3;1-3H/t21-,22+;;2*11-,12+;6-,7+; |
| InChIKey | ADWUSMYEQZDNEO-YVELOOADSA-N |
| XLogP | 9.07 |
| TPSA | 404.50 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 118 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1594.88 |
| LogP ≤ 5 | 9.07 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 31 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157084108 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.